Basilea Pharmaceutica AG BPMUF
Set alert
76.25 USD 0.00 0.00%
At close · Oct 30
77.40 Day range 77.40
59.29 52-week range 77.40
- YTD
- +20.55%
- 1 year
- +27.15%
- Open
- 77.40
- Prev close
- 76.25
- Mkt cap
- 945.05M
- Vol
- 100
- Avg vol
- 6
- EPS
- 5.05
- P/E
- 15.10
More statistics
- Low
- 77.40
- High
- 77.40
2Y chart
Signals (34)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| MACD: Sell Signal | Sep 4, 2026 | 1 month ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 2 months ago |
| RSI: Overbought | Aug 3, 2026 | 2 months ago |
| MACD: Buy Signal | Jun 26, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 10, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 4 months ago |
| SMA: Bearish | May 18, 2026 | 5 months ago |
| MACD: Sell Signal | May 18, 2026 | 5 months ago |
| MACD: Buy Signal | May 7, 2026 | 5 months ago |
| RSI: Oversold | Apr 15, 2026 | 6 months ago |
| SMA: Bearish | Apr 1, 2026 | 7 months ago |
| MACD: Sell Signal | Feb 2, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 26, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 22, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 5, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 31, 2025 | 10 months ago |
| SMA: Bullish | Dec 4, 2025 | 11 months ago |
| RSI: Overbought | Dec 4, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 11, 2025 | 11 months ago |
| RSI: Oversold | Oct 22, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 13, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 30, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 11, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 1, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 27, 2025 | 1 year ago |
| SMA: Bullish | Jun 6, 2025 | 1 year ago |
| RSI: Overbought | Jun 6, 2025 | 1 year ago |
| MACD: Buy Signal | May 8, 2025 | 1 year ago |
| SMA: Bearish | Apr 14, 2025 | 1 year ago |
| RSI: Oversold | Apr 14, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 11, 2025 | 1 year ago |
| RSI: Overbought | Mar 24, 2025 | 1 year ago |
News
- Basilea Pharmaceutica AG (BPMUF) Q2 2026 Earnings Call Transcript
- Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Short Interest Update
- Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
- Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting
- Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420
- Basilea announces start of first‑in‑human study of novel antibiotic BAL2420
- Basilea receives further USD 6 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
- Basilea Pharmaceutica AG (BPMUF) Q4 2025 Earnings Call Transcript
- Basilea reports strong 2025 full-year results, surpassing revenue and operating profit guidance
- Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
Your note
Sign in to keep a note on BPMUF — it syncs with the Stock Master app.